Patents by Inventor Devin Scott Quinlan

Devin Scott Quinlan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Engineered retrons and methods of use
    Patent number: 12054739
    Abstract: Disclosed are engineered retrons and methods of use such as to modify the genome of a host (e.g., mammalian) cell by delivering the engineered retron or the encoded ncRNA in vitro or in vivo to the host (e.g., mammalian) cell.
    Type: Grant
    Filed: September 22, 2023
    Date of Patent: August 6, 2024
    Assignee: RENAGADE THERAPEUTICS MANAGEMENT INC.
    Inventors: Alim Ladha, Vladimir Presnyak, Inna Shcherbakova, Brian Goodman, Mario Rodriguez Mestre, Devin Scott Quinlan, Muthusamy Jayaraman, Stephen Scully
  • ENGINEERED RETRONS AND METHODS OF USE
    Publication number: 20240175058
    Abstract: Disclosed are engineered retrons and methods of use such as to modify the genome of a host (e.g., mammalian) cell by delivering the engineered retron or the encoded ncRNA in vitro or in vivo to the host (e.g., mammalian) cell.
    Type: Application
    Filed: September 22, 2023
    Publication date: May 30, 2024
    Inventors: Alim Ladha, Vladimir Presnyak, Inna Shcherbakova, Brian Goodman, Mario Rodriguez Mestre, Devin Scott Quinlan, Muthusamy Jayaraman, Stephen Scully
  • Engineered retrons and methods of use
    Patent number: 11866728
    Abstract: Disclosed are engineered retrons and methods of use such as to modify the genome of a host (e.g., mammalian) cell by delivering the engineered retron or the encoded ncRNA in vitro or in vivo to the host (e.g., mammalian) cell.
    Type: Grant
    Filed: December 22, 2022
    Date of Patent: January 9, 2024
    Assignee: RENAGADE THERAPEUTICS MANAGEMENT INC.
    Inventors: Alim Ladha, Vladimir Presnyak, Inna Shcherbakova, Brian Goodman, Mario Rodriguez Mestre, Devin Scott Quinlan, Muthusamy Jayaraman, Stephen Scully
  • ENGINEERED RETRONS AND METHODS OF USE
    Publication number: 20230235365
    Abstract: Disclosed are engineered retrons and methods of use such as to modify the genome of a host (e.g., mammalian) cell by delivering the engineered retron or the encoded ncRNA in vitro or in vivo to the host (e.g., mammalian) cell.
    Type: Application
    Filed: December 22, 2022
    Publication date: July 27, 2023
    Applicant: ReNAgade Therapeutics Management Inc.
    Inventors: Alim Ladha, Vladimir Presnyak, Brian Goodman, Mario Rodriguez Mestre, Devin Scott Quinlan, Muthusamy Jayaraman, Stephen Scully